Skip to main content
. 2021 May 10;22(9):5034. doi: 10.3390/ijms22095034

Figure 2.

Figure 2

SIRT2 downregulation impairs the response of melanoma cells to EGF and cisplatin. The generated melanoma clones (SCM1 and SSM15 clones) were treated with selected concentrations of cisplatin for 48 h and then treated with EGF (EGFR activator) for 10 min, and protein lysates were prepared and analyzed by Western blotting.